FDA 510(k)

N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)

Número K: K233663 · 2023-12-13

RequerenteSiemens Healthcare Diagnostics Products GmbH

Data da decisão2023-12-13

Código do produtoCFN

Comité consultivoIM

DecisãoSubstantially Equivalent

Resumo do dispositivo

N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) is the device name listed in this FDA 510(k) record. The listed applicant is Siemens Healthcare Diagnostics Products GmbH. It received FDA 510(k) clearance on 2023-12-13 under 510(k) number K233663. The device is classified under product code CFN. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Perguntas frequentes

What is the N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)?

N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) is a medical device that received FDA 510(k) clearance on 2023-12-13. The listed applicant is Siemens Healthcare Diagnostics Products GmbH. The 510(k) number is K233663.

When did N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) receive FDA 510(k) clearance?

N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) received FDA 510(k) clearance on 2023-12-13, under 510(k) number K233663.

Who is the listed applicant for N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)?

The FDA 510(k) record lists Siemens Healthcare Diagnostics Products GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)?

The FDA product code for N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) is CFN.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Outros registros que listam Siemens Healthcare Diagnostics Products GmbH como candidato(a)

K240315INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban Controls (OPPS05)K220728vWF Ag K212559CardioPhase® hsCRP K212379N Latex FLC kappa, N Latex FLC lambda K201496N Latex FLC kappa, N Latex FLC lambda K193047N Latex FLC kappa, N Latex FLC lambda

Ver todos os 18 dispositivos →

Dispositivos Relacionados (Código: CFN)

K221114Immunoglobulin G (IgG)Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd.K192116Human IgA liquid reagent kit for Use on SPAPlusThe Binding Site Group , Ltd.K191985Optilite IgA KitThe Binding Site Group , Ltd.K191635Optilite IgM KitThe Binding Site Group , Ltd.K191465Human IgM Kit for use on SPAPlusThe Binding Site Group , Ltd.K190686Optilite IgM CSF KitThe Binding Site Group , Ltd.

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.